IL17A and metabolic dysfunction-associated steatotic liver disease: The KEGG analysis results, depicted in Figure 2b, primarily involve nonalcoholic fatty liver disease, insulin resistance, the IL-17 signaling pathway, and AGE-RAGE signaling in diabetic complications.